Page last updated: 2024-08-16

resveratrol and Pituitary Neoplasms

resveratrol has been researched along with Pituitary Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Firsching, R; Kirches, E; Mawrin, C; Melhem, O; Ochel, HJ; Rupa, R; Voellger, B; Waldt, N	1
Chu, M; Hu, ZQ; Li, CG; Wang, C; Wang, JS; Wang, LZ; Wang, Z; Zhang, WG	1

Other Studies

2 other study(ies) available for resveratrol and Pituitary Neoplasms

Article	Year
Combined effects of resveratrol and radiation in GH3 and TtT/GF pituitary adenoma cells. Journal of neuro-oncology, 2018, Volume: 139, Issue:3 Topics: Adenoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Chemoradiotherapy; Gamma Rays; Mice; Necrosis; Pituitary Neoplasms; Rats; Resveratrol; Tumor Cells, Cultured	2018
Resveratrol inhibited GH3 cell growth and decreased prolactin level via estrogen receptors. Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Cyclin D3; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Estrogen Receptor beta; G1 Phase; Humans; Indicators and Reagents; Microscopy, Electron, Transmission; Phosphorylation; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Estrogen; Resting Phase, Cell Cycle; Resveratrol; Stilbenes	2012

Article

Year

Combined effects of resveratrol and radiation in GH3 and TtT/GF pituitary adenoma cells.

Journal of neuro-oncology, 2018, Volume: 139, Issue:3

Topics: Adenoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Chemoradiotherapy; Gamma Rays; Mice; Necrosis; Pituitary Neoplasms; Rats; Resveratrol; Tumor Cells, Cultured

2018

Resveratrol inhibited GH3 cell growth and decreased prolactin level via estrogen receptors.

Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:3

Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Cyclin D3; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Estrogen Receptor beta; G1 Phase; Humans; Indicators and Reagents; Microscopy, Electron, Transmission; Phosphorylation; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Estrogen; Resting Phase, Cell Cycle; Resveratrol; Stilbenes

2012